Phase II trial of bisantrene in hepatocellular carcinoma: a Southwest Oncology Group Study.
Brown
T D
TD
Brooke Army Medical Center, Fort Sam Houston, TX.
Fleming
T R
TR
Shildt
R A
RA
Cowan
J D
JD
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000873:Anthracenes / Q000009:adverse effects / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D003953:Diagnosis-Related Groups; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced; D008113:Liver Neoplasms / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged
D000873:Anthracenes; C031404:bisantrene